A Study of AZD0486 in Subjects With B-Cell Non-Hodgkin Lymphoma

Clinical trial NCT04594642 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04594642
Sponsor: AstraZeneca
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

B-cell Non Hodgkin Lymphoma Diffuse Large B Cell Lymphoma High-grade B-cell Lymphoma Follicular Lymphoma

Start date: 2021-03-02
Primary completion: 2028-06-19
Enrollment: 226

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.